Form 4: OptimizeRx CCO Sells Shares for Tax Obligations

OptimizeRx Chief Commercial Officer Theresa Greco disposed of 1,693 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Theresa Greco, Chief Commercial Officer of OptimizeRx Corp (OPRX), reported a disposition of common stock.
• The transaction involved 1,693 shares of common stock.
• The shares were disposed of at a price of $20.49 per share.
• The disposition was made to satisfy tax withholding obligations upon the vesting of restricted stock units.
• Following this transaction, Theresa Greco beneficially owns 74,288 shares of OptimizeRx common stock.

Sentiment

Score: 5

Explanation: Neutral, as the transaction is a routine tax-related disposition of shares upon vesting of restricted stock units, not an open market sale reflecting a change in investment sentiment.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This transaction is a routine insider filing (Form 4) detailing a non-discretionary disposition of shares by an executive to cover tax obligations upon the vesting of restricted stock units. This is a common occurrence across publicly traded companies and does not typically reflect a change in the company's operational performance or strategic direction.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not indicate a change in the company's fundamentals or management's confidence.

Key Dates

Recommendation

The Form 4 details a routine, non-discretionary disposition of shares by a Chief Commercial Officer to cover tax obligations upon the vesting of restricted stock units. This transaction does not reflect a change in management's view of the company's prospects or a discretionary sale, thus it does not warrant a change in investment recommendation.

Keywords

OptimizeRx, OPRX, Form 4, Insider Transaction, Theresa Greco, Chief Commercial Officer, Tax Withholding, Restricted Stock Units, Equity Compensation